Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Claudin 9 (CLDN9) is an integral membrane protein and a member of the claudin family, a key component of tight junctions in epithelial and endothelial cells. It plays a role in maintaining cell polarity and regulating signal transduction. In the inner ear, it acts as a cation barrier, essential for hearing. It's also implicated in viral entry (Hepatitis C) and bacterial toxin binding, and is overexpressed in several cancers, making it a potential therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Claudin 9 (CLDN9).